Verified Nov 2026
Other
·

Warren, New Jersey
·
Since 2005
Aquestive Therapeutics is a specialty pharmaceutical company founded in 2005 and headquartered in Warren, New Jersey, with 100–200 employees and estimated revenue of $10–50 million. The company develops and commercializes medicines using proprietary thin-film drug-delivery technologies for neurological and allergy conditions. It serves medical and pharmaceutical markets, with five commercialized products including Sympazan for seizures and Libervant for seizure clusters, and operates manufacturing facilities in New Jersey and Indiana.
Aquestive Therapeutics at a glance
Revenue
$10-50M
Est. band
Employees
100-200
Founded
2005
Headquarters
Warren, New Jersey
Industries
Automotive
Electric Vehicles
Medical
Overview
Aquestive Therapeutics is a specialty pharmaceutical company founded in 2005 and headquartered in Warren, New Jersey, with 100–200 employees and estimated revenue of $10–50 million. The company develops and commercializes medicines using proprietary thin-film drug-delivery technologies for neurological and allergy conditions. It serves medical and pharmaceutical markets, with five commercialized products including Sympazan for seizures and Libervant for seizure clusters, and operates manufacturing facilities in New Jersey and Indiana.
At a glance
Attribute | Detail |
|---|---|
Founded | 2005 |
Headquarters | Warren, New Jersey |
Employees | 100-200 |
Revenue | $10-50M (estimated) |
What Aquestive Therapeutics makes
The company's PharmFilm and AdrenaVerse platforms deliver medications through oral soluble, buccal, or sublingual films, including a needle-free epinephrine treatment for anaphylaxis in late-stage development.
Latest developments
2026-11-09 — Press Releases | Aquestive Therapeutics (aquestive.com)
2026-11-04 — Aquestive (AQST) Q3 2026 Earnings Call Transcript | The Motley Fool (fool.com)
2026-10-14 — Eton Pharmaceuticals and Aquestive Therapeutics Announce Exclusive U.S. Licensing Agreement for LIBERVANT® (diazepam) Buccal Film | Aquestive Therapeutics (aquestive.com)
2026-05-13 — Aquestive Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update | Aquestive Therapeutics (aquestive.com)
2026-05-13 — Aquestive Therapeutics Completes $150MM Debt Refinancing with Oaktree - ABF Journal (abfjournal.com)
2026-05-12 — Aquestive Therapeutics Completes $150 Million Debt Refinancing with Oaktree | MarketScreener (marketscreener.com)
Facilities
Aquestive Therapeutics is headquartered in Warren, New Jersey. Public sources also reference these locations:
Portage, Indiana — biospace.com
New Jersey — sec.gov
Indiana — sec.gov
Company details
Aquestive completed a $150 million debt refinancing with Oaktree Capital in May 2026 to support operations and product commercialization. Aquestive Therapeutics was founded in 2005, has an estimated 100-200 employees, and is headquartered in Warren, New Jersey.
Frequently asked questions
What does Aquestive Therapeutics do?
Aquestive Therapeutics is a specialty pharmaceutical company founded in 2005 and headquartered in Warren, New Jersey, with 100–200 employees and estimated revenue of $10–50 million. The company develops and commercializes medicines using proprietary thin-film drug-delivery technologies for neurological and allergy conditions. It serves medical and pharmaceutical markets, with five commercialized products including Sympazan for seizures and Libervant for seizure clusters, and operates manufacturing facilities in New Jersey and Indiana.
Where is Aquestive Therapeutics headquartered?
Aquestive Therapeutics is headquartered in Warren, New Jersey (30 Technology Drive South, Warren, New Jersey, 07059).
When was Aquestive Therapeutics founded?
Aquestive Therapeutics was founded in 2005.
How big is Aquestive Therapeutics?
Aquestive Therapeutics has an estimated 100-200 employees, with revenue in the $10-50M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
